PlainRecalls
FDA Drug Moderate Class II Terminated

Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04

Reported: December 18, 2024 Initiated: September 11, 2024 #D-0116-2025

Product Description

Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04

Reason for Recall

cGMP Deviations: Temperature excursion

Details

Units Affected
5 cartons/20 units each carton
Distribution
Virgina
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 5 cartons/20 units each carton.
Why was this product recalled?
cGMP Deviations: Temperature excursion
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2024. Severity: Moderate. Recall number: D-0116-2025.